Latent tuberculosis infection and incident cardiovascular and non-cardiovascular death

Ita M Magodoro,Katalina A Wilkinson,Brian L Claggett,Aloice Aluoch,Mark J Siedner,Mpiko Ntsekhe,Ntobeko AB Ntusi,John M Nyirenda,Robert J Wilkinson

DOI: https://doi.org/10.1101/2024.03.11.24304070

2024-03-12

Abstract:Active tuberculosis may heighten the risk of incident cardiovascular morbidity and premature mortality, whereas whether latent TB infection (LTBI) recapitulates these adverse outcomes is unclear. We evaluated the effect of LTBI on all-cause and cardiovascular-specific death among US adults who underwent tuberculin skin testing in 1999-2000 and were followed up to December 31 , 2019. We also examined the impact of co-occuring traditional risk factors on these outcomes. Adjustments were made for socio-economic and demographic factors. LTBI was defined as tuberculin skin induration ≥10mm, and cause of death as cardiovascular if from heart or cerebrovascular diseases, and non-cardiovascular if otherwise. LTBI was associated with increased of overall and non-cardiovascular specific death but not cardiovascular-specific death. Risk of death was highest when LTBI was comorbid LTBI with diabetes. LTBI may increase risk of death by mechanisms other than progression to active TB disease.

Infectious Diseases (except HIV/AIDS)

What problem does this paper attempt to address?

This paper explores the relationship between latent tuberculosis infection (LTBI) and cardiovascular disease and non-cardiovascular mortality. The study is based on data from the 1999-2000 National Health and Nutrition Examination Survey in the United States, with follow-up until the end of 2019. It analyzes the impact of LTBI on all-cause mortality and cardiovascular-specific mortality, as well as the influence of coexisting traditional risk factors on these outcomes.

The study found that LTBI is associated with an increased all-cause mortality, particularly deaths caused by non-cardiovascular reasons, but it is not related to cardiovascular-specific mortality. The highest risk of death is observed in individuals with LTBI combined with diabetes. This suggests that LTBI may increase the risk of death through mechanisms other than progression to active tuberculosis.

The study also points out that although there is evidence showing an increased risk of cardiovascular disease in individuals with active tuberculosis, the association between LTBI and cardiovascular health is still unclear. Current research evidence is limited and mostly based on small, hospital-based studies, which may have potential biases. This study used a matched prospective cohort and although no significant differences were found in cardiovascular-specific survival rates, it suggests that LTBI may affect long-term overall survival, especially in individuals with comorbid diabetes.

Therefore, this paper emphasizes the need for further research on the specific mechanisms linking LTBI and mortality, particularly in tuberculosis endemic areas. Additionally, considering screening and managing traditional risk factors in LTBI patients may be an important component of prevention strategies.